Advancing Aggregation-Induced Emission-Derived Biomaterials in Viral, Tuberculosis, and Fungal Infectious Diseases

Abstract

Contagious diseases caused by different types of highly contagious pathogens, such as SARS-CoV-2, monkeypox virus, Mycobacterium tuberculosis, and human immunodeficiency virus, could trigger global outbreaks and bring a huge public health burden. Advanced diagnostic, therapeutic, and preventive strategies are urgently needed to deal with the epidemic of contagious diseases. Aggregation-induced emission (AIE) has emerged as one of the promising candidates that exhibit tunable photophysical properties, high biocompatibility, exceptional photostability, and a distinguishing aggregation-enhanced fluorescence. As a result, they offer effective strategies for the diagnosis, treatment, and prevention of contagious diseases. This review systematically outlined the latest research progress of AIE-based biomaterials and mechanisms in contagious diseases. The versatility of AIE molecules, as well as highly efficient fluorescence properties, has the potential to offer innovative strategies to combat these health challenges. Thanks to recent advances in materials science and a better understanding of aggregation-induced emission luminogens (AIEgens), AIEgens have great potential to provide better solutions for the treatment, detection, and prevention of contagious diseases. By reviewing state-of-the-art methods for the killing, detection, and prevention of contagious agents and highlighting promising technological developments, this outlook aims to promote the development of new means for the prevention and control of emerging, re-emerging, and major contagious diseases as well as further research and development activities in this critical area of research.

Keywords

aggregation-induced emission / contagious diseases / detection / fungi / human immunodeficiency virus / monkeypox / personal protective equipment SARS-CoV-2 / therapy / tuberculosis

References

[1] A. R. Kirtane, M. Verma, P. Karandikar, J. Furin, R. Langer, and G. Traverso, “Nanotechnology Approaches for Global Infectious Diseases,” Nature Nanotechnology 16 (2021): 369-384.

[2] D. M. Morens, G. K. Folkers, and A. S. Fauci, “The Challenge of Emerging and Re-Emerging Infectious Diseases,” Nature 430 (2004): 242-249.

[3] R. J. Murphy, “Communicable Diseases in Humanitarian Operations and Disasters,” BMJ Military Health 168 (2022): 457-461.

[4] F. Wu, S. Zhao, B. Yu, et al., “A New Coronavirus Associated With Human Respiratory Disease in China,” Nature 579 (2020): 265-269.

[5] A. Gessain, E. Nakoune, and Y. Yazdanpanah, “Monkeypox,” New England Journal of Medicine 387 (2022): 1783-1793.

[6] G. B. Melikyan, “HIV Entry: A Game of Hide-and-Fuse?” Current Opinion in Virology 4 (2014): 1-7.

[7] A. Koch and V. Mizrahi, “Mycobacterium tuberculosis,” Trends in Microbiology 26 (2018): 555-556.

[8] B. D. Kevadiya, J. Machhi, J. Herskovitz, et al., “Diagnostics for SARS-CoV-2 Infections,” Nature Materials 20 (2021): 593-605.

[9] M. Saraf, M. Tavakkoli Yaraki, Prateek, and R. K. Gupta, “Insights and Perspectives Regarding Nanostructured Fluorescent Materials Toward Tackling COVID-19 and Future Pandemics,” ACS Applied Nano Materials 4 (2021): 911-948.

[10] S. Mueller, “Facing the 2020 Pandemic: What Does Cyberbiosecurity Want us to Know to Safeguard the Future?” Biosafety and Health 3 (2021): 11-21.

[11] M. S. Sofi, A. Hamid, and S. U. Bhat, “SARS-CoV-2: A Critical Review of its History, Pathogenesis, Transmission, Diagnosis and Treatment,” Biosafety and Health 2 (2020): 217-225.

[12] C. Steininger, M. Kundi, S. W. Aberle, J. H. Aberle, and T. Popow-Kraupp, “Effectiveness of Reverse Transcription-PCR, Virus Isolation, and Enzyme-Linked Immunosorbent Assay for Diagnosis of Influenza A Virus Infection in Different Age Groups,” Journal of Clinical Microbiology 40 (2002): 2051-2056.

[13] Z. Shen, Y. Xiao, L. Kang, et al., “Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019,” Clinical Infectious Diseases 71 (2020): 713-720.

[14] L. Váradi, J. L. Luo, D. E. Hibbs, et al., “Methods for the Detection and Identification of Pathogenic Bacteria: Past, Present, and Future,” Chemical Society Reviews 46 (2017): 4818-4832.

[15] Y. Li, J. Lan, and G. Wong, “Advances in Treatment Strategies for COVID-19: Insights From Other Coronavirus Diseases and Prospects,” Biosafety and Health 5 (2023): 272-279.

[16] H. Li, L. Zhao, K. Huang, et al., “Viral Rebound and Safety of Nirmatrelvir/Ritonavir for Lung-Transplant Recipients Infected With SARS-CoV-2,” Biosafety and Health 5 (2023): 266-271.

[17] X. Liu and S. Zhang, “COVID-19: Face Masks and Human-to-Human Transmission,” Influenza and Other Respiratory Viruses 14 (2020): 472-473.

[18] P. Laskar, M. M. Yallapu, and S. C. Chauhan, ““Tomorrow Never Dies”: Recent Advances in Diagnosis, Treatment, and Prevention Modalities Against Coronavirus (COVID-19) amid Controversies,” Diseases 8 (2020): 30.

[19] S. A. Jenekhe and J. A. Osaheni, “Excimers and Exciplexes of Conjugated Polymers,” Science 265 (1994): 765-768.

[20] R. Hu, N. L. Leung, and B. Z. Tang, “AIE Macromolecules: Syntheses, Structures and Functionalities,” Chemical Society Reviews 43 (2014): 4494-4562.

[21] J. Xu, M. Huang, H. Pang, et al., “C─H···π Interaction Induced H-Aggregates for Wide Range Water Content Detection in Organic Solvents,” Aggregate 5 (2024): e546.

[22] J. Luo, Z. Xie, J. W. Lam, et al., “Aggregation-Induced Emission of 1-Methyl-1,2,3,4,5-Pentaphenylsilole,” Chemical Communications no. 18 (2001): 1740-1741.

[23] X. He, L. H. Xiong, Z. Zhao, et al., “AIE-Based Theranostic Systems for Detection and Killing of Pathogens,” Theranostics 9 (2019): 3223-3248.

[24] M. Maruthi and S. K. Kalangi, “Advances in Aggregation Induced Emission (AIE) Materials in Biosensing and Imaging of Bacteria,” Progress in Molecular Biology and Translational Science 184 (2021): 61-79.

[25] L. Huang, M. Cai, Q. Qiao, T. Li, J. Chen, and X. Jiang, “Water Soluble AIEgen-Based Thermosensitive and Antibacterial Hydroxypropyl Chitin Hydrogels for Non-Invasive Visualization and Wound Healing,” Carbohydrate Polymers 319 (2023): 121186.

[26] X. Huang, C. Chu, C. Shi, et al., “Seeing is Believing: Efficiency Evaluation of Multifunctional Ionic-Dependent AIEgens for Tuberculosis,” Biomaterials 302 (2023): 122301.

[27] B. Hou, F. Yang, C. Hu, et al., “A Novel Bifunctional Nanoplatform With Aggregation-Induced Emission Property for Efficient Photodynamic Killing of Bacteria and Wound Healing,” Infection and Drug Resistance 15 (2022): 7351-7361.

[28] S. Ning, M. Lyu, D. Zhu, et al., “Type-I AIE Photosensitizer Loaded Biomimetic System Boosting Cuproptosis to Inhibit Breast Cancer Metastasis and Rechallenge,” ACS Nano 17 (2023): 10206-10217.

[29] Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The Species Severe Acute Respiratory Syndrome-Related Coronavirus: Classifying 2019-nCoV and Naming it SARS-CoV-2. Nature Microbiology 5 (2020): 536-544.

[30] Z. Ke, J. Oton, K. Qu, et al., “Structures and Distributions of SARS-CoV-2 Spike Proteins on Intact Virions,” Nature 588 (2020): 498-502.

[31] Z. Hu, W. Wang, Y. Lin, et al., “Extracellular Vesicle-Inspired Therapeutic Strategies for the COVID-19,” Advanced Healthcare Materials 13 (2024): e2402103.

[32] I. S. Mahmoud, Y. B. Jarrar, W. Alshaer, and S. Ismail, “SARS-CoV-2 Entry in Host Cells-Multiple Targets for Treatment and Prevention,” Biochimie 175 (2020): 93-98.

[33] P. Zhou, X. L. Yang, X. G. Wang, et al., “A Pneumonia Outbreak Associated With a New Coronavirus of Probable Bat Origin,” Nature 579 (2020): 270-273.

[34] M. Hoffmann, H. Kleine-Weber, S. Schroeder, et al., “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor,” Cell 181 (2020): 271-280.E8.

[35] L. Horndler, P. Delgado, D. Abia, et al., “Flow Cytometry Multiplexed Method for the Detection of Neutralizing Human Antibodies to the Native SARS-CoV-2 Spike Protein,” EMBO Molecular Medicine 13 (2021): e13549.

[36] C. P. Thompson, N. E. Grayson, R. S. Paton, et al., “Detection of Neutralising Antibodies to SARS-CoV-2 to Determine Population Exposure in Scottish Blood Donors Between March and May 2020,” Euro Surveillance 25 (2020): 2000685.

[37] I. Smyrlaki, M. Ekman, A. Lentini, et al., “Massive and Rapid COVID-19 Testing is Feasible by Extraction-Free SARS-CoV-2 RT-PCR,” Nature Communications 11 (2020): 4812.

[38] J. Mei, Y. Hong, J. W. Lam, A. Qin, Y. Tang, and B. Z. Tang, “Aggregation-Induced Emission: The Whole is More Brilliant Than the Parts,” Advanced Materials 26 (2014): 5429-5479.

[39] J. Zhang, N. Wang, X. Ji, Y. Tao, J. Wang, and W. Zhao, “BODIPY-Based Fluorescent Probes for Biothiols,” Chemistry - A European Journal 26 (2020): 4172-4192.

[40] B. S. Miller, L. Bezinge, H. D. Gliddon, et al., “Spin-Enhanced Nanodiamond Biosensing for Ultrasensitive Diagnostics,” Nature 587 (2020): 588-593.

[41] C. Parolo and A. Merkoçi, “Paper-Based Nanobiosensors for Diagnostics,” Chemical Society Reviews 42 (2013): 450-457.

[42] C. Parolo, A. de la Escosura-Muñiz, and A. Merkoçi, “Enhanced Lateral Flow Immunoassay Using Gold Nanoparticles Loaded With Enzymes,” Biosensors & Bioelectronics 40 (2013): 412-416.

[43] K. Tanneeru, N. K. Bhatraju, R. S. Bhosale, and S. K. Kalangi, “Assessing Differential Binding of Aggregation-Induced Emission-Based Luminogens to Host Interacting Surface Proteins of SARS-CoV-2 and Influenza Virus-An In Silico Approach,” Frontiers in Microbiology 12 (2021): 766351.

[44] R. Chen, C. Ren, M. Liu, et al., “Early Detection of SARS-CoV-2 Seroconversion in Humans With Aggregation-Induced Near-Infrared Emission Nanoparticle-Labeled Lateral Flow Immunoassay,” ACS Nano 15 (2021): 8996-9004.

[45] L. Bian, Z. Li, A. He, et al., “Ultrabright Nanoparticle-Labeled Lateral Flow Immunoassay for Detection of anti-SARS-CoV-2 Neutralizing Antibodies in Human Serum,” Biomaterials 288 (2022): 121694.

[46] L. Hao, W. Yang, Y. Xu, et al., “Engineering Light-Initiated Afterglow Lateral Flow Immunoassay for Infectious Disease Diagnostics,” Biosensors & Bioelectronics 212 (2022): 114411.

[47] Y. Cheng, A. E. Clark, J. Zhou, et al., “Protease-Responsive Peptide-Conjugated Mitochondrial-Targeting AIEgens for Selective Imaging and Inhibition of SARS-CoV-2-Infected Cells,” ACS Nano 16 (2022): 12305-12317.

[48] Y. Cheng, A. E. Clark, W. Yim, et al., “Protease-Responsive Potential-Tunable AIEgens for Cell Selective Imaging of TMPRSS2 and Accurate Inhibitor Screening,” Analytical Chemistry 95 (2023): 3789-3798.

[49] P. L. Truong, Y. Yin, D. Lee, and S. H. Ko, “Advancement in COVID-19 Detection Using Nanomaterial-Based Biosensors,” Exploration 3 (2023): 20210232.

[50] Z. Liu, T. Meng, X. Tang, R. Tian, and W. Guan, “The Promise of Aggregation-Induced Emission Luminogens for Detecting COVID-19,” Frontiers in Immunology 12 (2021): 635558.

[51] Y. X. Yuan, H. C. Zhang, M. Hu, et al., “Enhanced DNA Sensing and Chiroptical Performance by Restriction of Double-Bond Rotation of AIE cis-Tetraphenylethylene Macrocycle Diammoniums,” Organic Letters 22 (2020): 1836-1840.

[52] A. Gupta, T. Adarsh, V. Manchanda, P. K. Sasmal, and S. Gupta, “COVID-19 Detection Using AIE-Active Iridium Complexes,” Dalton Transactions 52 (2023): 1188-1192.

[53] Q. Zhang, B. Yin, J. Hao, et al., “An AIEgen/Graphene Oxide Nanocomposite (AIEgen@GO)-Based Two-Stage “Turn-On” Nucleic Acid Biosensor for Rapid Detection of SARS-CoV-2 Viral Sequence,” Aggregate 4 (2023): e195.

[54] G. S. Ravi Kumara, A. Pandith, and Y. J. Seo, “Highly Fluorescent Morpholine Naphthalimide Deoxyuridine Nucleotide for the Detection of miRNA 24-3P Through Rolling Circle Amplification,” Analyst 145 (2020): 4777-4781.

[55] D. W. Trobaugh and W. B. Klimstra, “MicroRNA Regulation of RNA Virus Replication and Pathogenesis,” Trends in Molecular Medicine 23 (2017): 80-93.

[56] M. Panda, E. Kalita, S. Singh, K. Kumar, A. Rao, and V. K. Prajapati, “MiRNA-SARS-CoV-2 Dialogue and Prospective anti-COVID-19 Therapies,” Life Sciences 305 (2022): 120761.

[57] J. W. Park, “Principles and Applications of Loop-Mediated Isothermal Amplification to Point-of-Care Tests,” Biosensors 12 (2022): 857.

[58] S. Bi, S. Yue, and S. Zhang, “Hybridization Chain Reaction: A Versatile Molecular Tool for Biosensing, Bioimaging, and Biomedicine,” Chemical Society Reviews 46 (2017): 4281-4298.

[59] B. C. Yin, Y. Q. Liu, and B. C. Ye, “One-Step, Multiplexed Fluorescence Detection of microRNAs Based on Duplex-Specific Nuclease Signal Amplification,” Journal of the American Chemical Society 134 (2012): 5064-5067.

[60] J. S. Hartig, I. Grüne, S. H. Najafi-Shoushtari, and M. Famulok, “Sequence-Specific Detection of MicroRNAs by Signal-Amplifying Ribozymes,” Journal of the American Chemical Society 126 (2004): 722-723.

[61] H. Lu, T. Hailin, X. Yi, and J. Wang, “Three-Dimensional DNA Nanomachine Combined With Toehold-Mediated Strand Displacement Reaction for Sensitive Electrochemical Detection of MiRNA,” Langmuir 36 (2020): 10708-10714.

[62] F. Li, J. Li, B. Dong, F. Wang, C. Fan, and X. Zuo, “DNA Nanotechnology-Empowered Nanoscopic Imaging of Biomolecules,” Chemical Society Reviews 50 (2021): 5650-5667.

[63] J. Luo, P. Yang, J. Cheng, et al., “Photosensitizers With Aggregation-Induced Far-Red/Near-Infrared Emission for Versatile Visualization and Broad-Spectrum Photodynamic Killing of Pathogenic Microbes,” Journal of Colloid & Interface Science 634 (2023): 664-674.

[64] N. Dhas, K. Parekh, A. Pandey, R. Kudarha, S. Mutalik, and T. Mehta, “Two Dimensional Carbon Based Nanocomposites as Multimodal Therapeutic and Diagnostic Platform: A Biomedical and Toxicological Perspective,” Journal of Controlled Release 308 (2019): 130-161.

[65] H. Bai, W. He, J. H. C. Chau, et al., “AIEgens for Microbial Detection and Antimicrobial Therapy,” Biomaterials 268 (2021): 120598.

[66] K. Yang, L. Feng, X. Shi, and Z. Liu, “Nano-Graphene in Biomedicine: Theranostic Applications,” Chemical Society Reviews 42 (2013): 530-547.

[67] A. Wiehe, J. M. O'Brien, and M. O. Senge, “Trends and Targets in Antiviral Phototherapy,” Photochemical & Photobiological Sciences 18 (2019): 2565-2612.

[68] S. Gao, X. Yan, G. Xie, et al., “Membrane Intercalation-Enhanced Photodynamic Inactivation of Bacteria by a Metallacycle and TAT-Decorated Virus Coat Protein,” Proceedings of the National Academy Sciences of the United States of America 116 (2019): 23437-23443.

[69] S. S. Lucky, K. C. Soo, and Y. Zhang, “Nanoparticles in Photodynamic Therapy,” Chemical Reviews 115 (2015): 1990-2042.

[70] L. Chen, X. Wang, Y. Yuan, et al., “Photosensitizers With Aggregation-Induced Emission and Their Biomedical Applications,” Engineered Regeneration 3 (2022): 59-72.

[71] M. Y. Wu, M. Gu, J. K. Leung, et al., “A Membrane-Targeting Photosensitizer With Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses,” Small 17 (2021): e2101770.

[72] M. Lu, H. Xing, W. Shao, et al., “Photoactivatable Silencing Extracellular Vesicle (PASEV) Sensitizes Cancer Immunotherapy,” Advanced Materials 34 (2022): e2204765.

[73] B. Li, W. Wang, L. Zhao, et al., “Multifunctional AIE Nanosphere-Based “Nanobomb” for Trimodal Imaging-Guided Photothermal/Photodynamic/Pharmacological Therapy of Drug-Resistant Bacterial Infections,” ACS Nano 17 (2023): 4601-4618.

[74] Y. He, S. Zhang, Y. She, et al., “Innovative Utilization of Cell Membrane-Coated Nanoparticles in Precision Cancer Therapy,” Exploration (Early View): https://doi.org/10.1002/exp.20230164.

[75] M. Yang, J. Zhou, L. Lu, et al., “Tumor Cell Membrane-Based Vaccines: A Potential Boost for Cancer Immunotherapy,” Exploration (Early View): https://doi.org/10.1002/exp.20230171.

[76] H. Cao, Y. Yang, and J. Li, “AIEgen-Lipid Structures: Assembly and Biological Applications,” Aggregate 1 (2020): 69-79.

[77] K. Jin, Z. Luo, B. Zhang, and Z. Pang, “Biomimetic Nanoparticles for Inflammation Targeting,” Acta Pharmaceutica Sinica B 8 (2018): 23-33.

[78] Y. Liu, J. Luo, X. Chen, W. Liu, and T. Chen, “Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications,” Nano-Micro Letters 11 (2019): 100.

[79] J. Zheng, T. Chen, K. Wang, et al., “Engineered Multifunctional Zinc-Organic Framework-Based Aggregation-Induced Emission Nanozyme for Accelerating Spinal Cord Injury Recovery,” ACS Nano 18 (2024): 2355-2369.

[80] Q. Xia, Y. Zhang, Z. Li, X. Hou, and N. Feng, “Red Blood Cell Membrane-Camouflaged Nanoparticles: A Novel Drug Delivery System for Antitumor Application,” Acta Pharmaceutica Sinica B 9 (2019): 675-689.

[81] B. Li, W. Wang, W. Song, et al., “Antiviral and Anti-Inflammatory Treatment with Multifunctional Alveolar Macrophage-Like Nanoparticles in a Surrogate Mouse Model of COVID-19,” Advanced Science 8 (2021): 1-14.

[82] A. Maus, L. Strait, and D. Zhu, “Nanoparticles as Delivery Vehicles for Antiviral Therapeutic Drugs,” Engineered Regeneration 2 (2021): 31-46.

[83] Y. Wu, Y. Liu, T. Wang, Q. Jiang, F. Xu, and Z. Liu, “Living Cell for Drug Delivery,” Engineered Regeneration 3 (2022): 131-148.

[84] C. Zheng, D. Zhang, Y. Kong, et al., “Dynamic Regulation of Drug Biodistribution by Turning Tumors Into Decoys for Biomimetic Nanoplatform to Enhance the Chemotherapeutic Efficacy of Breast Cancer With Bone Metastasis,” Exploration 3 (2023): 20220124.

[85] X. Chen, M. Zhao, Q. Xie, et al., “Click-Hydrogel Delivered Aggregation-Induced Emissive Nanovesicles for Simultaneous Remodeling and Antibiosis of Deep Burn Wounds,” Aggregate 5 (2024): e406.

[86] H. Guan, W. Wang, Z. Jiang, et al., “Magnetic Aggregation-Induced Bone-Targeting Nanocarrier With Effects of Piezo1 Activation and Osteogenic-Angiogenic Coupling for Osteoporotic Bone Repair,” Advanced Materials 36 (2024): e2312081.

[87] X. Li, J. F. Lovell, J. Yoon, and X. Chen, “Clinical Development and Potential of Photothermal and Photodynamic Therapies for Cancer,” Nature Reviews Clinical Oncology 17 (2020): 657-674.

[88] W. Li, J. Yang, L. Luo, et al., “Targeting Photodynamic and Photothermal Therapy to the Endoplasmic Reticulum Enhances Immunogenic Cancer Cell Death,” Nature Communications 10 (2019): 3349.

[89] Z. Iqbal, J. Chen, Z. Chen, and M. Huang, “Phthalocyanine-Biomolecule Conjugated Photosensitizers for Targeted Photodynamic Therapy and Imaging,” Current Drug Metabolism 16 (2015): 816-832.

[90] V. Mashayekhi, E. Schooten, P. M. P. van Bergen En Henegouwen, M. M. Kijanka, and S. Oliveira, “Nanobody-Targeted Photodynamic Therapy: Nanobody Production and Purification,” Methods in Molecular Biology 2451 (2022): 481-493.

[91] D. Luo, K. A. Carter, D. Miranda, and J. F. Lovell, “Chemophototherapy: An Emerging Treatment Option for Solid Tumors,” Advanced Science 4 (2017): 1600106.

[92] E. Zhao, Y. Chen, H. Wang, et al., “Light-Enhanced Bacterial Killing and Wash-Free Imaging Based on AIE Fluorogen,” ACS Applied Materials & Interfaces 7 (2015): 7180-7188.

[93] J. Wang, J. Li, Z. Shen, D. Wang, and B. Z. Tang, “Phospholipid-Mimetic Aggregation-Induced Emission Luminogens for Specific Elimination of Gram-Positive and Gram-Negative Bacteria,” ACS Nano 17 (2023): 4239-4249.

[94] H. Chen, S. Li, M. Wu, Z. H. Kenry, C. S. Lee, and B. Liu, “Membrane-Anchoring Photosensitizer With Aggregation-Induced Emission Characteristics for Combating Multidrug-Resistant Bacteria,” Angewandte Chemie International Edition 59 (2020): 632-636.

[95] M. M. S. Lee, E. Y. Yu, D. Yan, et al., “The Role of Structural Hydrophobicity on Cationic Amphiphilic Aggregation-Induced Emission Photosensitizer-Bacterial Interaction and Photodynamic Efficiency,” ACS Nano 17 (2023): 17004-17020.

[96] T. Wu, Y. Fu, S. Guo, et al., “Self-Assembly Multifunctional DNA Tetrahedron for Efficient Elimination of Antibiotic-Resistant Bacteria,” Aggregate 5 (2024): e402.

[97] Z. S. Moore, J. F. Seward, and J. M. Lane, “Smallpox,” Lancet 367 (2006): 425-435.

[98] E. Petersen, A. Kantele, M. Koopmans, et al., “Human Monkeypox,” Infectious Disease Clinics of North America 33 (2019): 1027-1043.

[99] L. Liu, Z. Xu, R. C. Fuhlbrigge, V. Peña-Cruz, J. Lieberman, and T. S. Kupper, “Vaccinia Virus Induces Strong Immunoregulatory Cytokine Production in Healthy Human Epidermal Keratinocytes: A Novel Strategy for Immune Evasion,” Journal of Virology 79 (2005): 7363-7370.

[100] D. T. MacLeod, T. Nakatsuji, Z. Wang, A. di Nardo, and R. L. Gallo, “Vaccinia Virus Binds to the Scavenger Receptor MARCO on the Surface of Keratinocytes,” Journal of Investigative Dermatology 135 (2015): 142-150.

[101] O. Mitjà, D. Ogoina, B. K. Titanji, et al., “Monkeypox,” Lancet 401 (2023): 60-74.

[102] Y. Ma, M. Song, L. Li, X. Lao, M. C. Wong, and J. Hao, “Advances in Upconversion Luminescence Nanomaterial-Based Biosensor for Virus Diagnosis,” Exploration 2 (2022): 20210216.

[103] E. De Clercq, Y. Jiang, and G. Li, “Therapeutic Strategies for Human Poxvirus Infections: Monkeypox (mpox), Smallpox, Molluscipox, and Orf,” Travel Medicine and Infectious Disease 52 (2023): 102528.

[104] J. G. Rizk, G. Lippi, B. M. Henry, D. N. Forthal, and Y. Rizk, “Prevention and Treatment of Monkeypox,” Drugs 82 (2022): 957-963.

[105] J. Bayry, E. A. Ahmed, D. Toscano-Rivero, et al., “Intravenous Immunoglobulin: Mechanism of Action in Autoimmune and Inflammatory Conditions,” Journal of Allergy and Clinical Immunology Practice 11 (2023): 1688-1697.

[106] H. Yang, J. Zheng, W. Wang, et al., “Zr-MOF Carrier-Enhanced Dual-Mode Biosensing Platforms for Rapid and Sensitive Diagnosis of Mpox,” Advanced Science 11 (2024): 2405848.

[107] B. Li, W. Wang, L. Zhao, et al., “Aggregation-Induced Emission-Based Macrophage-Like Nanoparticles for Targeted Photothermal Therapy and Virus Transmission Blockage in Monkeypox,” Advanced Materials 36 (2023): e2305378.

[108] E. Lazear, L. W. Peterson, C. A. Nelson, and D. H. Fremont, “Crystal Structure of the Cowpox Virus-Encoded NKG2D Ligand OMCP,” Journal of Virology 87 (2013): 840-850.

[109] W. Wang, B. Li, Y. Wu, et al., “Macrophage-Derived Biomimetic Nanoparticles for Light-Driven Theranostics Toward Mpox,” Matter 7 (2024): 1187-1206.

[110] J. Sun and X. He, “AIE-Based Drug/Gene Delivery System: Evolution from Fluorescence Monitoring alone to Augmented Therapeutics,” Aggregate 3 (2022): e282.

[111] J. W. Rausch and S. F. Le Grice, “HIV Rev Assembly on the Rev Response Element (RRE): A Structural Perspective,” Viruses 7 (2015): 3053-3075.

[112] A. D. Frankel and J. A. Young, “HIV-1: Fifteen Proteins and an RNA,” Annual Review of Biochemistry 67 (1998): 1-25.

[113] M. J. Gait and J. Karn, “RNA Recognition by the Human Immuno-Deficiency Virus Tat and Rev Proteins,” Trends in Biochemical Sciences 18 (1993): 255-259.

[114] E. Fanales-Belasio, M. Raimondo, B. Suligoi, and S. Buttò, “HIV Virology and Pathogenetic Mechanisms of Infection: A Brief Overview,” Annali dell'Istituto Superiore di Sanita 46 (2010): 5-14.

[115] N. W. Luedtke and Y. Tor, “Fluorescence-Based Methods for Evaluating the RNA Affinity and Specificity of HIV-1 Rev-RRE Inhibitors,” Biopolymers 70 (2003): 103-119.

[116] L. G. Bekker, G. Alleyne, S. Baral, et al., “Advancing Global Health and Strengthening the HIV Response in the Era of the Sustainable Development Goals: The International AIDS Society—Lancet Commission,” Lancet 392 (2018): 312-358.

[117] J. Li, Y. Y. Fan, M. Wang, et al., “A Light-Up Strategy With Aggregation-Induced Emission for Identification of HIV-I RNA-Binding Small Molecules,” Analytical Chemistry 92 (2020): 13532-13538.

[118] J. Li, Y. Y. Fan, J. Wen, J. Zhang, and Z. Q. Zhang, “Metal-Enhanced Aggregation-Induced Emission Strategy for the HIV-I RNA-Binding Ligand Assay,” Analytical Chemistry 94 (2022): 4695-4702.

[119] Y. Bai, E. Y. Yu, Y. Liu, et al., “Molecular Engineering of AIE Photosensitizers for Inactivation of Rabies Virus,” Small 19 (2023): e2303542.

[120] L. H. Xiong, X. He, Z. Zhao, et al., “Ultrasensitive Virion Immunoassay Platform With Dual-Modality Based on a Multifunctional Aggregation-Induced Emission Luminogen,” ACS Nano 12 (2018): 9549-9557.

[121] C. C. Ma, L. Li, S. Cai, et al., “Development of an HPV Genotype Detection Platform Based on Aggregation-Induced Emission (AIE) and Flow-Through Hybridization Technologies,” Molecules 27 (2022): 7036.

[122] H. Shi, J. Liu, J. Geng, B. Z. Tang, and B. Liu, “Specific Detection of Integrin α_vβ₃ by Light-Up Bioprobe With Aggregation-Induced Emission Characteristics,” Journal of the American Chemical Society 134 (2012): 9569-9572.

[123] H. Ashiba, M. Yasuura, T. Fukuda, K. Hatano, and M. Fujimaki, “Quick and Ultra-Sensitive Digital Assay of Influenza Virus Using Sub-Picoliter Microwells,” Analytica Chimica Acta 1213 (2022): 339926.

[124] H. Chang, Y. Mei, Y. Li, and L. Shang, “An AIE and ESIPT Based Neuraminidase Fluorescent Probe for Influenza Virus Detection and Imaging,” Talanta 247 (2022): 123583.

[125] T. C. Owyong, P. Subedi, J. Deng, et al., “A Molecular Chameleon for Mapping Subcellular Polarity in an Unfolded Proteome Environment,” Angewandte Chemie International Edition 59 (2020): 10129-10135.

[126] H. Taye, K. Alemu, A. Mihret, et al., “Global Prevalence of Mycobacterium Bovis Infections Among Human Tuberculosis Cases: Systematic Review and Meta-Analysis,” Zoonoses Public Health 68 (2021): 704-718.

[127] A. Abbara and R. N. Davidson, “Etiology and Management of Genitourinary Tuberculosis,” Nature Reviews Urology 8 (2011): 678-688.

[128] A. Zumla, P. Nahid, and S. T. Cole, “Advances in the Development of New Tuberculosis Drugs and Treatment Regimens,” Nature Reviews Drug Discovery 12 (2013): 388-404.

[129] L. Zhang, Y. Zhao, Y. Gao, et al., “Structures of Cell Wall Arabinosyltransferases With the Anti-Tuberculosis Drug Ethambutol,” Science 368 (2020): 1211-1219.

[130] M. Marija, “Rifampicin: An Immunosuppressant?” Lancet 298 (1971): 930-931.

[131] W. Shi, X. Zhang, X. Jiang, et al., “Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis,” Science 333 (2011): 1630-1632.

[132] Z. Lan, N. Ahmad, P. Baghaei, et al., “Drug-Associated Adverse Events in the Treatment of Multidrug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis,” Lancet Respiratory Medicine 8 (2020): 383-394.

[133] K. Dheda, R. M. Warren, A. Zumla, and M. P. Grobusch, “Extensively Drug-Resistant Tuberculosis: Epidemiology and Management Challenges,” Infectious Disease Clinics of North America 24 (2010): 705-725.

[134] B. Acharya, A. Acharya, S. Gautam, et al., “Advances in diagnosis of Tuberculosis: An update Into Molecular Diagnosis of Mycobacterium tuberculosis,” Molecular Biology Reports 47 (2020): 4065-4075.

[135] H. C. Kolb, M. G. Finn, and K. B. Sharpless, “Click Chemistry: Diverse Chemical Function From a Few Good Reactions,” Angewandte Chemie International Edition 40 (2001): 2004-2021.

[136] H. W. Kavunja, K. J. Biegas, N. Banahene, et al., “Photoactivatable Glycolipid Probes for Identifying Mycolate-Protein Interactions in Live Mycobacteria,” Journal of the American Chemical Society 142 (2020): 7725-7731.

[137] G. Dai, P. Zhao, L. Song, et al., “Devising Novel Near-Infrared Aggregation-Induced-Emission Luminogen Labeling for Point-of-Care Diagnosis of Mycobacterium tuberculosis,” Bioscience Trends 17 (2023): 234-238.

[138] W. Hong, L. Chen, and J. Xie, “Molecular basis Underlying Mycobacterium tuberculosis D-Cycloserine Resistance. Is There a Role for Ubiquinone and Meraquinone Metabolic Pathways?” Expert Opinion on Therapeutic Targets 18 (2014): 691-701.

[139] Y. Liao, B. Li, Z. Zhao, et al., “Targeted Theranostics for Tuberculosis: A Rifampicin-Loaded Aggregation-Induced Emission Carrier for Granulomas Tracking and Anti-Infection,” ACS Nano 14 (2020): 8046-8058.

[140] B. Li, W. Wang, L. Zhao, et al., “Photothermal Therapy of Tuberculosis Using Targeting Pre-Activated Macrophage Membrane-Coated Nanoparticles,” Nature Nanotechnology 19 (2024): 824-845.

[141] S. A. Dilliard and D. J. Siegwart, “Passive, Active and Endogenous Organ-Targeted Lipid and Polymer Nanoparticles for Delivery of Genetic Drugs,” Nature Reviews Materials 8 (2023): 282-300.

[142] Y. Liu, W. Zhen, Y. Wang, et al., “One-Dimensional Fe₂P Acts as a Fenton Agent in Response to NIR II Light and Ultrasound for Deep Tumor Synergetic Theranostics,” Angewandte Chemie International Edition 58 (2019): 2407-2412.

[143] I. Suárez, S. M. Fünger, S. Kröger, J. Rademacher, G. Fätkenheuer, and J. Rybniker, “The Diagnosis and Treatment of Tuberculosis,” Deutsches Arzteblatt International 116 (2019): 729-735.

[144] M. M. S. Lee, W. Xu, L. Zheng, et al., “Ultrafast Discrimination of Gram-Positive Bacteria and Highly Efficient Photodynamic Antibacterial Therapy Using Near-Infrared Photosensitizer with Aggregation-Induced Emission Characteristics,” Biomaterials 230 (2020): 119582.

[145] H. Wang, B. Li, and Y. Sun, et al., “NIR-II AIE Luminogen-Based Erythrocyte-Like Nanoparticles with Granuloma-Targeting and Self-Oxygenation Characteristics for Combined Phototherapy of Tuberculosis,” Advanced Materials 36 (2024): 2406143.

[146] P. Jain, D. S. Thaler, M. Maiga, et al., “Reporter Phage and Breath Tests: Emerging Phenotypic Assays for Diagnosing Active Tuberculosis, Antibiotic Resistance, and Treatment Efficacy,” Journal of Infectious Diseases 204 (2011): S1142-S1150.

[147] K. Thiel, “Old Dogma, New Tricks—21st Century Phage Therapy,” Nature Biotechnology 22 (2004): 31-36.

[148] A. Khawaldeh, S. Morales, B. Dillon, et al., “Bacteriophage Therapy for Refractory Pseudomonas aeruginosa Urinary Tract Infection,” Journal of Medical Microbiology 60 (2011): 1697-1700.

[149] C. Duplessis, B. Biswas, B. Hanisch, et al., “Refractory Pseudomonas Bacteremia in a 2-Year-Old Sterilized by Bacteriophage Therapy,” Journal of the Pediatric Infectious Diseases Society 7 (2018): 253-256.

[150] B. Subramanyam, G. N. Sivaramakrishnan, A. Dusthackeer, S. Nagamiah, and V. Kumar, “Phage Lysin as a Substitute for Antibiotics to Detect Mycobacterium tuberculosis from Sputum Samples with the BACTEC MGIT 960 System,” Clinical Microbiology and Infection 18 (2012): 497-501.

[151] M. R. O'Donnell, A. Pym, P. Jain, et al., “A Novel Reporter Phage To Detect Tuberculosis and Rifampin Resistance in a High-HIV-Burden Population,” Journal of Clinical Microbiology 53 (2015): 2188-2194.

[152] R. M. Dedrick, C. A. Guerrero-Bustamante, R. A. Garlena, et al., “Engineered Bacteriophages for Treatment of a Patient with a Disseminated Drug-resistant Mycobacterium abscessus,” Nature Medicine 25 (2019): 730-733.

[153] C. A. Guerrero-Bustamante, R. M. Dedrick, R. A. Garlena, D. A. Russell, and G. F. Hatfull, “Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages Against Diverse Mycobacterium tuberculosis Strains,” mBio 12 (2021): e00973-21.

[154] X. He, Y. Yang, Y. Guo, et al., “Phage-Guided Targeting, Discriminative Imaging, and Synergistic Killing of Bacteria by AIE Bioconjugates,” Journal of the American Chemical Society 142 (2020): 3959-3969.

[155] M. Y. Wu, L. Chen, Q. Chen, et al., “Engineered Phage with Aggregation-Induced Emission Photosensitizer in Cocktail Therapy Against Sepsis,” Advanced Materials 35 (2023): e2208578.

[156] S. Mattila, P. Ruotsalainen, and M. Jalasvuori, “On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy,” Frontiers in Microbiology 6 (2015): 1271.

[157] D. J. Malik, I. J. Sokolov, G. K. Vinner, et al., “Formulation, Stabilisation and Encapsulation of Bacteriophage for Phage Therapy,” Advances in Colloid and Interface Science 249 (2017): 100-133.

[158] T. Luu, W. Li, N. M. O'Brien-Simpson, and Y. Hong, “Recent Applications of Aggregation Induced Emission Probes for Antimicrobial Peptide Studies,” Chemistry—An Asian Journal 16 (2021): 1027-1040.

[159] R. Ramakrishnan, A. V. Nair, K. Parmar, R. S. Rajmani, D. Chakravortty, and D. Das, “Combating Biofilm-Associated Klebsiella pneumoniae Infections Using a Bovine Microbial Enzyme,” Npj Biofilms and Microbiomes 10 (2024): 119.

[160] C. Cillóniz, C. Dominedò, and A. Torres, “Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia,” Critical Care 23 (2019): 79.

[161] M. Zasloff, “Antimicrobial Peptides of Multicellular Organisms,” Nature 415 (2002): 389-395.

[162] M. Ferri, E. Ranucci, P. Romagnoli, and V. Giaccone, “Antimicrobial Resistance: A Global Emerging Threat to Public Health Systems,” Critical Reviews in Food Science and Nutrition 57 (2017): 2857-2876.

[163] J. Chen, M. Gao, L. Wang, et al., “Aggregation-Induced Emission Probe for Study of the Bactericidal Mechanism of Antimicrobial Peptides,” ACS Applied Materials & Interfaces 10 (2018): 11436-11442.

[164] M. D. Seo, H. S. Won, J. H. Kim, T. Mishig-Ochir, and B. J. Lee, “Antimicrobial Peptides for Therapeutic Applications: A Review,” Molecules 17 (2012): 12276-12286.

[165] N. N. Li, J. Z. Li, P. Liu, et al., “An Antimicrobial Peptide with an Aggregation-induced Emission (AIE) Luminogen for Studying Bacterial Membrane Interactions and Antibacterial Actions,” Chemical Communications 53 (2017): 3315-3318.

[166] M. AlMatar, E. A. Makky, G. Yakıcı, I. Var, B. Kayar, and F. Köksal, “Antimicrobial Peptides as an Alternative to Anti-tuberculosis Drugs,” Pharmacological Research 128 (2018): 288-305.

[167] G. Hao, Y. H. Shi, Y. L. Tang, and G. W. Le, “The Intracellular Mechanism of Action on Escherichia coli of BF2-A/C, Two Analogues of the Antimicrobial Peptide Buforin 2,” Journal of Microbiology 51 (2013): 200-206.

[168] V. Sosunov, V. Mischenko, B. Eruslanov, et al., “Antimycobacterial Activity of Bacteriocins and Their Complexes With Liposomes,” Journal of Antimicrobial Chemotherapy 59 (2007): 919-925.

[169] G. E. Purdy and D. G. Russell, “Lysosomal Ubiquitin and the Demise of Mycobacterium tuberculosis,” Cellular Microbiology 9 (2007): 2768-2774.

[170] Y. J. Cheng, J. J. Hu, S. Y. Qin, A. Q. Zhang, and X. Z. Zhang, “Recent Advances in Functional Mesoporous Silica-Based Nanoplatforms for Combinational Photo-chemotherapy of Cancer,” Biomaterials 232 (2020): 119738.

[171] J. M. Liebler and C. J. Markin, “Fiberoptic Bronchoscopy for Diagnosis and Treatment,” Critical Care Clinics 16 (2000): 83-100.

[172] P. Agostinis, K. Berg, K. A. Cengel, et al., “Photodynamic Therapy of Cancer: An Update,” CA: A Cancer Journal for Clinicians 61 (2011): 250-281.

[173] N. Sung, S. Back, J. Jung, et al., “Inactivation of Multidrug Resistant (MDR)- and Extensively Drug Resistant (XDR)-Mycobacterium tuberculosis by Photodynamic Therapy,” Photodiagnosis Photodynamic Therapy 10 (2013): 694-702.

[174] S. R. Wiegell, B. Kongshoj, and H. C. Wulf, “Mycobacterium marinum Infection Cured by Photodynamic Therapy,” Archives of Dermatology 142 (2006): 1241-1242.

[175] K. P. Hartnett, K. A. Jackson, C. Felsen, et al., “Bacterial and Fungal Infections in Persons Who Inject Drugs—Western New York, 2017,” MMWR Morbidity and Mortality Weekly Report 68 (2019): 583-586.

[176] M. C. Fisher, N. J. Hawkins, D. Sanglard, and S. J. Gurr, “Worldwide Emergence of Resistance to Antifungal Drugs Challenges Human Health and Food Security,” Science 360 (2018): 739-742.

[177] O. A. Cornely, M. Hoenigl, C. Lass-Flörl, et al., “Defining Breakthrough Invasive Fungal Infection-Position Paper of the Mycoses Study Group Education and Research Consortium and the European Confederation of Medical Mycology,” Mycoses 62 (2019): 716-729.

[178] H. Bai, H. Chen, R. Hu, et al., “Supramolecular Conjugated Polymer Materials for in Situ Pathogen Detection,” ACS Applied Materials & Interfaces 8 (2016): 31550-31557.

[179] Y. Wang, T. S. Corbitt, S. D. Jett, et al., “Direct Visualization of Bactericidal Action of Cationic Conjugated Polyelectrolytes and Oligomers,” Langmuir 28 (2012): 65-70.

[180] J. R. Köhler, B. Hube, R. Puccia, A. Casadevall, and J. R. Perfect, “Fungi That Infect Humans,” Microbiology Spectrum 5 (2017): FUNK-0014-2016.

[181] T. Li, Y. Wu, W. Cai, et al., “Vision Defense: Efficient Antibacterial AIEgens Induced Early Immune Response for Bacterial Endophthalmitis,” Advanced Science 9 (2022): e2202485.

[182] C. Zhou, M. Jiang, J. Du, et al., “One Stone, Three Birds: One AIEgen with Three Colors for Fast Differentiation of Three Pathogens,” Chemical Science 11 (2020): 4730-4740.

[183] X. Ge, M. Gao, B. Situ, et al., “One-step, Rapid Fluorescence Sensing of Fungal Viability Based on a Bioprobe with Aggregation-induced Emission Characteristics,” Materials Chemistry Frontiers 4 (2020): 957-964.

[184] X. Ge, M. Gao, B. He, et al., “Rapid and High-Throughput Testing of Antifungal Susceptibility Using an AIEgen-Based Analytical System,” Biomaterials 287 (2022): 121618.

[185] M. Y. Wu, X. Xu, R. Hu, et al., “A Membrane-Targeted Photosensitizer Prevents Drug Resistance and Induces Immune Response in Treating Candidiasis,” Advanced Science 10 (2023): e2207736.

[186] R. Hu, Q. Deng, Q. Tang, et al., “More Is Less: Creation of Pathogenic Microbe-related Theranostic Oriented AIEgens,” Biomaterials 271 (2021): 120725.

[187] K. Zhou, S. Wang, L. Xu, et al., “AIEgen-Based Smart System for Fungal-Infected Wound Monitoring and On-Demand Photodynamic Therapy,” Matter 6 (2023): 3449-3462.

[188] C. Zhou, C. Peng, C. Shi, et al., “Mitochondria-Specific Aggregation-Induced Emission Luminogens for Selective Photodynamic Killing of Fungi and Efficacious Treatment of Keratitis,” ACS Nano 15 (2021): 12129-12139.

[189] W. Zhu, Y. Li, S. Guo, et al., “Stereoisomeric Engineering of Aggregation-induced Emission Photosensitizers towards Fungal Killing,” Nature Communications 13 (2022): 7046.

[190] M. E. Tomas, S. Kundrapu, P. Thota, et al., “Contamination of Health Care Personnel During Removal of Personal Protective Equipment,” JAMA Internal Medicine 175 (2015): 1904-1910.

[191] J. Sun, Y. Bai, E. Y. Yu, et al., “Self-Cleaning Wearable Masks for Respiratory Infectious Pathogen Inactivation by Type I and Type II AIE Photosensitizer,” Biomaterials 291 (2022): 121898.

[192] M. Li, H. Wen, H. Li, et al., “AIEgen-Loaded Nanofibrous Membrane as Photodynamic/Photothermal Antimicrobial Surface for Sunlight-Triggered Bioprotection,” Biomaterials 276 (2021): 121007.

[193] B. Li, D. Wang, M. M. S. Lee, et al., “Fabrics Attached With Highly Efficient Aggregation-Induced Emission Photosensitizer: Toward Self-Antiviral Personal Protective Equipment,” ACS Nano 15 (2021): 13857-13870.

[194] G. Q. Zhang, Z. Gao, J. Zhang, et al., “A Wearable AIEgen-Based Lateral Flow Test Strip for Rapid Detection of SARS-CoV-2 RBD Protein and N Protein,” Cell Reports Physical Science 3 (2022): 100740.

[195] WHO. “World Health Statistics 2023: Monitoring Health for the SDGs, Sustainable Development Goals,” World Health Organization, accessed May 19, 2023, https://www.who.int/publications/i/item/9789240074323.

[196] W. Gu, S. Miller, and C. Y. Chiu, “Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection,” Annual Review of Pathology 14 (2019): 319-338.

[197] S. He, L. G. Leanse, and Y. Feng, “Artificial Intelligence and Machine Learning Assisted Drug Delivery for Effective Treatment of Infectious Diseases,” Advanced Drug Delivery Reviews 178 (2021): 113922.

[198] M. A. Cook and G. D. Wright, “The Past, Present, and Future of Antibiotics,” Science Translational Medicine 14 (2022): eabo7793.

[199] M. A. Liu, “Vaccine Developments,” Nature Medicine 4 (1998): 515-519.

[200] J. H. Verbeek, S. Ijaz, C. Mischke, et al., “Personal Protective Equipment for Preventing Highly Infectious Diseases due to Exposure to Contaminated Body Fluids in Healthcare Staff,” Cochrane Database of Systematic Reviews 4 (2016): Cd011621.

[201] S. Liu, G. Feng, B. Z. Tang, and B. Liu, “Recent Advances of AIE Light-up Probes for Photodynamic Therapy,” Chemical Science 12 (2021): 6488-6506.

[202] C. Wang, Y. Wang, L. Zhang, et al., “Pretreated Macrophage-Membrane-Coated Gold Nanocages for Precise Drug Delivery for Treatment of Bacterial Infections,” Advanced Materials 30 (2018): e1804023.

[203] D. Wang, M. M. S. Lee, G. Shan, et al., “Highly Efficient Photosensitizers With Far-Red/Near-Infrared Aggregation-Induced Emission for in Vitro and in Vivo Cancer Theranostics,” Advanced Materials 30 (2018): e1802105.

[204] D. Wang, M. M. S. Lee, W. Xu, R. T. K. Kwok, J. W. Y. Lam, and B. Z. Tang, “Theranostics Based on AIEgens,” Theranostics 8 (2018): 4925-4956.

[205] Z. Zheng, T. Zhang, H. Liu, et al., “Bright Near-Infrared Aggregation-Induced Emission Luminogens With Strong Two-Photon Absorption, Excellent Organelle Specificity, and Efficient Photodynamic Therapy Potential,” ACS Nano 12 (2018): 8145-8159.

[206] W. Zhu, L. Huang, C. Wu, L. Liu, and H. Li, “Reviewing the Evolutive ACQ-to-AIE Transformation of Photosensitizers for Phototheranostics,” Luminescence 39 (2023): e4655.

[207] Z. Qiu, X. Yu, J. Zhang, et al., “Fibrous Aggregates: Amplifying Aggregation-Induced Emission to Boost Health Protection,” Biomaterials 287 (2022): 121666.

[208] J. Ni, Y. Wang, H. Zhang, J. Z. Sun, and B. Z. Tang, “Aggregation-Induced Generation of Reactive Oxygen Species: Mechanism and Photosensitizer Construction,” Molecules 26 (2021): 268.

[209] H. Li, B. Jin, Y. Wang, B. Deng, D. Wang, and B. Z. Tang, “As Fiber Meets With AIE: Opening a Wonderland for Smart Flexible Materials,” Advanced Materials 35 (2023): e2210085.

[210] V. A. Svyatchenko, S. D. Nikonov, A. P. Mayorov, M. L. Gelfond, and V. B. Loktev, “Antiviral Photodynamic Therapy: Inactivation and Inhibition of SARS-CoV-2 in Vitro Using Methylene Blue and Radachlorin,” Photodiagnosis and Photodynamic Therapy 33 (2021): 102112.

[211] H. Cao, H. Gao, L. Wang, et al., “Biosynthetic Dendritic Cell-Exocytosed Aggregation-Induced Emission Nanoparticles for Synergistic Photodynamic Immunotherapy,” ACS Nano 16 (2022): 13992-14006.

RIGHTS & PERMISSIONS

2024 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.